Global hearing technology leaders Starkey and MED-EL are bringing their exclusive collaboration to life with the introduction of DualSync, a bimodal streaming partnership enabling Apple technology to seamlessly stream to compatible Starkey hearing aids and MED-EL cochlear implants.
This partnership brings together the strength of Starkey’s industry-leading hearing aids with the innovation behind MED-EL’s cochlear implants, creating a seamless and unified wireless audio experience for people who rely on both technologies.
Beginning July 1, 2025, Starkey Edge AI and Genesis AI hearing aids and MED-EL Sonnet 3, Sonnet 2, Sonnet, and Rondo 3 audio processors will be compatible for bimodal streaming. The solution is designed to support a growing ecosystem of devices and will be compatible with future innovations from both companies. DualSync technology provides seamless audio connectivity and synchronized sound from compatible smartphones and media devices, empowering users with more natural, connected hearing.
“Hearing loss takes many forms and, in some cases, multiple technologies are required for the best outcome of the patient,” said Brandon Sawalich, President and CEO of Starkey. “Two global tech leaders are combining world-class innovations to connect more people back to the things they love most. Partnering with MED-EL reflects our shared commitment to delivering excellence without exception.”
“By uniting two leading technologies, we are delivering a global solution that gives bimodal users effortless connectivity, clearer sound, and greater control in their daily lives,” added Dr. Ingeborg Hochmair, co-founder and CEO of MED-EL. “Our shared goal is simple: to make it easier for people everywhere to hear, communicate, and engage with the world – using the most advanced technology available.”
The companies say this collaboration reflects a shared commitment to patient-first innovation, personalised care, and expanding access to the latest in hearing technology available to users worldwide.
